Literature DB >> 19370732

The use of a color coded probability scale to interpret smell tests in suspected parkinsonism.

Laura Silveira-Moriyama1, Aviva Petrie, David R Williams, Andrew Evans, Regina Katzenschlager, Egberto R Barbosa, Andrew J Lees.   

Abstract

Smell identification tests (SITs) have been suggested as useful in the differential diagnosis of Parkinson's disease (PD). We have applied the 40 item University of Pennsylvania SIT (UPSIT-40) and/or the 16 item SIT from Sniffin Sticks (SS-16) to 193 nondemented PD patients and 157 controls and used logistic regression analysis to associate the SIT result with the probability of an individual patient having PD ("PD probability"). Reliability measures (95% CI) using the clinical diagnosis as a gold standard and a dichotomized result of the smell test into high (50% or more) or low (<50%) "PD probability" were: sensitivity 85.0% (78.8-89.7%), specificity 84.6% (77.3-89.9%) for the UPSIT-40; sensitivity 90.4% (83.5-94.7%), specificity 85.5% (76.2-91.7%) for the SS-16. Based on these findings we have created color coded visual tools (PD probability rulers) and applied them to 39 clinically uncertain parkinsonian syndromes (CUPS) patients who had been investigated with dopamine transporter SPECT scanning using [123-I]-FP-CIT SPECT (DaTSCAN) for suspected Parkinson's disease. In 32 of 36 CUPS cases (88.9%, kappa = 0.72) the probability ruler predicted the result of the DaTSCAN. We suggest smell tests could be used routinely in challenging cases where there is diagnostic uncertainty and help inform decision making relating to the need for neuro imaging. (c) 2009 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19370732     DOI: 10.1002/mds.22494

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  9 in total

1.  Extended extraocular phenotype of PROM1 mutation in kindreds with known autosomal dominant macular dystrophy.

Authors:  Francesca I Arrigoni; Mar Matarin; Pamela J Thompson; Michel Michaelides; Michelle E McClements; Elizabeth Redmond; Lindsey Clarke; Elizabeth Ellins; Saifullah Mohamed; Ian Pavord; Nigel Klein; David M Hunt; Anthony T Moore; Julian Halcox; Sanjay M Sisodiya
Journal:  Eur J Hum Genet       Date:  2010-09-22       Impact factor: 4.246

2.  Screening for VPS35 mutations in Parkinson's disease.

Authors:  Una-Marie Sheerin; Gavin Charlesworth; Jose Bras; Rita Guerreiro; Kailash Bhatia; Thomas Foltynie; Patricia Limousin; Laura Silveira-Moriyama; Andrew Lees; Nicholas Wood
Journal:  Neurobiol Aging       Date:  2011-12-07       Impact factor: 4.673

3.  Tracking Parkinson's: Study Design and Baseline Patient Data.

Authors:  Naveed Malek; Diane M A Swallow; Katherine A Grosset; Michael A Lawton; Sarah L Marrinan; Alexander C Lehn; Catherine Bresner; Nin Bajaj; Roger A Barker; Yoav Ben-Shlomo; David J Burn; Thomas Foltynie; John Hardy; Huw R Morris; Nigel M Williams; Nicholas Wood; Donald G Grosset
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

4.  Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction.

Authors:  Katerina Markopoulou; Bruce A Chase; Piotr Robowski; Audrey Strongosky; Ewa Narożańska; Emilia J Sitek; Mariusz Berdynski; Maria Barcikowska; Matt C Baker; Rosa Rademakers; Jarosław Sławek; Christine Klein; Katja Hückelheim; Meike Kasten; Zbigniew K Wszolek
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

5.  Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin' Sticks test in patients with Parkinson's disease.

Authors:  Michael Lawton; Michele T M Hu; Fahd Baig; Claudio Ruffmann; Eilidh Barron; Diane M A Swallow; Naveed Malek; Katherine A Grosset; Nin Bajaj; Roger A Barker; Nigel Williams; David J Burn; Thomas Foltynie; Huw R Morris; Nicholas W Wood; Margaret T May; Donald G Grosset; Yoav Ben-Shlomo
Journal:  Parkinsonism Relat Disord       Date:  2016-09-25       Impact factor: 4.891

6.  Multi-modal Brain MRI in Subjects with PD and iRBD.

Authors:  Silvia Mangia; Alena Svatkova; Daniele Mascali; Mikko J Nissi; Philip C Burton; Petr Bednarik; Edward J Auerbach; Federico Giove; Lynn E Eberly; Michael J Howell; Igor Nestrasil; Paul J Tuite; Shalom Michaeli
Journal:  Front Neurosci       Date:  2017-12-19       Impact factor: 4.677

7.  An Unsupervised Neural Network Feature Selection and 1D Convolution Neural Network Classification for Screening of Parkinsonism.

Authors:  Tariq Saeed Mian
Journal:  Diagnostics (Basel)       Date:  2022-07-25

8.  Premotor biomarkers for Parkinson's disease - a promising direction of research.

Authors:  Brian R Haas; Tessandra H Stewart; Jing Zhang
Journal:  Transl Neurodegener       Date:  2012-05-31       Impact factor: 8.014

9.  Clinical prodromes of neurodegeneration in Anderson-Fabry disease.

Authors:  Matthias Löhle; Derralynn Hughes; Alan Milligan; Linda Richfield; Heinz Reichmann; Atul Mehta; Anthony H V Schapira
Journal:  Neurology       Date:  2015-03-11       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.